Details for Patent: 10,207,066
✉ Email this page to a colleague
Which drugs does patent 10,207,066 protect, and when does it expire?
Patent 10,207,066 protects TOBI PODHALER and is included in one NDA.
This patent has fifteen patent family members in thirteen countries.
Summary for Patent: 10,207,066
| Title: | Aerosolization apparatus with capsule puncture alignment guide |
| Abstract: | An aerosolization apparatus comprises a housing defining a chamber having one or more air inlets. The chamber is sized to receive a capsule which contains an aerosolizable pharmaceutical formulation. The aerosolization apparatus further comprises a puncturing mechanism within the housing. The puncturing mechanism comprises an alignment guide and a puncture member, wherein the alignment guide comprises a surface adapted to contact the capsule while the puncture member is advanced into the capsule to create an opening in the capsule. At least a portion of the surface is sloped relative to the longitudinal axis of the capsule. Alternatively or additionally, the surface may comprise one or more protrusions. An end section is associated with the housing. The end section is sized and shaped to be received in a user's mouth or nose so that the user may inhale through the end section to inhale aerosolized pharmaceutical formulation that has exited the capsule through the opening created in the capsule. The alignment guide allows for more consistent puncturing of the capsule and a longer lifetime of the apparatus. |
| Inventor(s): | Dunkley; Michael John (Nottingham, GB), Tuckwell; Jon David (Cambridgeshire, GB), Vernon-Harcourt; Edward William (Cambridge, GB), Glusker; Mark (San Mateo, CA), Paboojian; Steve (Menlo Park, CA) |
| Assignee: | BGP Products Operations GmbH (CH) |
| Application Number: | 10/821,624 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 10,207,066 |
|
Patent Claim Types: see list of patent claims | Use; Formulation; Delivery; Device; Dosage form; |
Drugs Protected by US Patent 10,207,066
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mylan Speciality Lp | TOBI PODHALER | tobramycin | POWDER;INHALATION | 201688-001 | Mar 22, 2013 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | TREATMENT OF CYSTIC FIBROSIS PATIENTS WITH PSEUDOMONAS AERUGINOSA | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 10,207,066
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2004229512 | ⤷ Sign Up | |||
| Canada | 2520265 | ⤷ Sign Up | |||
| Cyprus | 1117408 | ⤷ Sign Up | |||
| Denmark | 1615689 | ⤷ Sign Up | |||
| European Patent Office | 1615689 | ⤷ Sign Up | |||
| Spain | 2564165 | ⤷ Sign Up | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
